Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Novel potent maturation inhibitors developed by DFH Pharma

March 14, 2013

KM-023 demonstrates good tolerance and pharmacokinetics in a phase I trial

March 8, 2013

VAC-3S immunotherapeutic proves safe and well tolerated in HIV-1

March 8, 2013

MK-1439 shows good safety and efficacy in previously untreated HIV-infected patients

March 7, 2013

GSK-744 LAP proves effective in monkeys with SHIV infection

March 7, 2013

Scientists at Bristol-Myers Squibb prepare novel agents for HIV infection

March 7, 2013

Health Canada declines to approve Theratechnologies' NDS for Egrifta

March 5, 2013

Biosantech initiates phase I/II trial of synthetic AIDS vaccine Tat Oyi

March 5, 2013

ViiV Healthcare grants voluntary license to increase access to HIV medicine for children

March 1, 2013

FDA grants priority review to dolutegravir NDA

Feb. 18, 2013

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...